献血者高血糖水平影响血液工作安全性的研究进展

赵广超, 毛平平, 齐清, 等. 献血者高血糖水平影响血液工作安全性的研究进展[J]. 临床血液学杂志, 2023, 36(8): 603-606. doi: 10.13201/j.issn.1004-2806.2023.08.016
引用本文: 赵广超, 毛平平, 齐清, 等. 献血者高血糖水平影响血液工作安全性的研究进展[J]. 临床血液学杂志, 2023, 36(8): 603-606. doi: 10.13201/j.issn.1004-2806.2023.08.016
ZHAO Guangchao, MAO Pingping, QI Qing, et al. Advances in research on impact of hyperglycemia in blood donors on safety of blood donation[J]. J Clin Hematol, 2023, 36(8): 603-606. doi: 10.13201/j.issn.1004-2806.2023.08.016
Citation: ZHAO Guangchao, MAO Pingping, QI Qing, et al. Advances in research on impact of hyperglycemia in blood donors on safety of blood donation[J]. J Clin Hematol, 2023, 36(8): 603-606. doi: 10.13201/j.issn.1004-2806.2023.08.016

献血者高血糖水平影响血液工作安全性的研究进展

  • 基金项目:
    全军重大“战场急救应急采供血技术和装置研究”项目(No:ANJ13J001)
详细信息
    通讯作者: 王伟,E-mail:wwnjmu@126.com
  • 中图分类号: R457

Advances in research on impact of hyperglycemia in blood donors on safety of blood donation

More Information
  • 随着中国社会发展和生活环境的复杂化,人们的血糖水平已逐渐改变,糖尿病患者逐年增加。然而,高血糖环境影响血液成分的质量,关系到临床输血的安全性,同时高血糖献血者在献血过程中较易发生献血不良反应,影响献血顺利进行和献血者的保留。献血前进行血糖筛查是一项可行性高、廉价方便且有价值的服务。因此从高血糖水平分别对血液质量和对献血工作的影响展开综述,进一步分析了献血前筛查血糖的必要性和可行性,为献血前血糖筛查工作的开展和研究提供参考。
  • 加载中
  • [1]

    中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志, 2021, 13(4): 315-409. https://www.cnki.com.cn/Article/CJFDTOTAL-HBYX202112018.htm

    [2]

    Chowdhury N. Diabetes mellitus in the context of blood transfusion[J]. J Pak Med Assoc, 2017, 67(3): 480-481.

    [3]

    Mali AV, Bhise SS, Hegde MV, et al. Altered erythrocyte glycolytic enzyme activities in type-Ⅱ diabetes[J]. Indian J Clin Biochem, 2016, 31(3): 321-325. doi: 10.1007/s12291-015-0529-6

    [4]

    Mali AV, Bhise SS, Katyare SS, et al. Altered kinetics properties of erythrocyte lactate dehydrogenase in type Ⅱ diabetic patients and its implications for lactic acidosis[J]. Indian J Clin Biochem, 2018, 33(1): 38-45. doi: 10.1007/s12291-017-0637-6

    [5]

    Bardyn M, Rappaz B, Jaferzadeh K, et al. Red blood cells ageing markers: a multi-parametric analysis[J]. Trasfusione Del Sangue, 2017, 15(3): 239-248.

    [6]

    Singh Y, Chowdhury A, Dasgupta R, et al. The effects of short term hyperglycemia on human red blood cells studied using Raman spectroscopy and optical trap[J]. Eur Biophys J, 2021, 50(6): 867-876. doi: 10.1007/s00249-021-01541-5

    [7]

    Szablewski L, Sulima A. The structural and functional changes of blood cells and molecular components in diabetes mellitus[J]. Biol Chem, 2017, 398(4): 411-423. doi: 10.1515/hsz-2016-0196

    [8]

    Morabito R, Remigante A, Spinelli S, et al. High glucose concentrations affect band 3 protein in human erythrocytes[J]. Antioxidants(Basel), 2020, 9(5): 365.

    [9]

    张紫薇, 周晓芳, 郭建荣. 高血糖对红细胞理化性质及免疫功能影响的研究进展[J]. 临床输血与检验, 2021, 23(5): 677-680. https://www.cnki.com.cn/Article/CJFDTOTAL-LSXY202105029.htm

    [10]

    Gkaliagkousi E, Nikolaidou B, Gavriilaki E, et al. Increased erythrocyte-and platelet-derived microvesicles in newly diagnosed type 2 diabetes mellitus[J]. Diab Vasc Dis Res, 2019, 16(5): 458-465. doi: 10.1177/1479164119844691

    [11]

    De Pergola G, Giagulli VA, Guastamacchia E, et al. Platelet number is positively and independently associated with glycated hemoglobin in non-diabetic overweight and obese subjects[J]. Nutr Metab Cardiovasc Dis, 2019, 29(3): 254-259. doi: 10.1016/j.numecd.2018.12.007

    [12]

    Bhatta S, Singh S, Gautam S, et al. Mean platelet volume and platelet count in patients with type 2 diabetes mellitus and impaired fasting glucose[J]. J Nepal Health Res Counc, 2019, 16(41): 392-395. doi: 10.33314/jnhrc.v16i41.1502

    [13]

    Zaccardi F, Rocca B, Rizzi A, et al. Platelet indices and glucose control in type 1 and type 2 diabetes mellitus: a case-control study[J]. Nutr Metab Cardiovasc Dis, 2017, 27(10): 902-909. doi: 10.1016/j.numecd.2017.06.016

    [14]

    Przygodzki T, Luzak B, Kassassir H, et al. Diabetes and hyperglycemia affect platelet GPⅢa expression. effects on adhesion potential of blood platelets from diabetic patients under in vitro flow conditions[J]. Int J Mol Sci, 2020, 21(9): 3222. doi: 10.3390/ijms21093222

    [15]

    Eichner NZM, Gilbertson NM, Musante L, et al. An oral glucose load decreases postprandial extracellular vesicles in obese adults with and without prediabetes[J]. Nutrients, 2019, 11(3): 580. doi: 10.3390/nu11030580

    [16]

    Santilli F, Zaccardi F, Liani R, et al. In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance[J]. Diabetes Metab Res Rev, 2020, 36(2): e3232.

    [17]

    Santilli F, Simeone P, Liani R, et al. Platelets and diabetes mellitus[J]. Prostaglandins Other Lipid Mediat, 2015, 120: 28-39. doi: 10.1016/j.prostaglandins.2015.05.002

    [18]

    Li XL, Weber NC, Cohn DM, et al. Effects of hyperglycemia and diabetes mellitus on coagulation and hemostasis[J]. J Clin Med, 2021, 10(11): 2419. doi: 10.3390/jcm10112419

    [19]

    Hörber S, Lehmann R, Fritsche L, et al. Lifestyle intervention improves prothrombotic coagulation profile in individuals at high risk for type 2 diabetes[J]. J Clin Endocrinol Metab, 2021, 106(8): e3198-e3207. doi: 10.1210/clinem/dgab124

    [20]

    van der Toorn FA, de Mutsert R, Lijfering WM, et al. Glucose metabolism affects coagulation factors: the NEO study[J]. J Thromb Haemost, 2019, 17(11): 1886-1897. doi: 10.1111/jth.14573

    [21]

    Gentile NT, Rao AK, Reimer H, et al. Coagulation markers and functional outcome in acute ischemic stroke: impact of intensive versus standard hyperglycemia control[J]. Res Pract Thromb Haemost, 2021, 5(5): e12563. doi: 10.1002/rth2.12563

    [22]

    Kryukov EV, Kuchmin AN, Umanskaya EP, et al. The main pathogenetic mechanisms of hypercoagulation in diabetes and the possibility of its drug correction[J]. Bull Russ Mil Med Acad, 2021, 23(2): 165-174. doi: 10.17816/brmma64995

    [23]

    于微, 傅钰, 冯里茹, 等. 自发性肥胖型糖尿病大鼠血浆蛋白组学分析[J]. 武汉大学学报(理学版), 2021, 67(5): 489-495. https://www.cnki.com.cn/Article/CJFDTOTAL-WHDY202105011.htm

    [24]

    Antwi-Baffour S. Alterations in plasma glucose levels among blood donors[J]. Eur J Prev Med, 2014, 2(2): 25. doi: 10.11648/j.ejpm.20140202.12

    [25]

    Debecho DA, Hailu A. Assessment of blood donation safety by people diagnosed with diabetes, hypertension, malaria and cancer[J]. J Adv Med Med Res, 2019: 1-8.

    [26]

    Namba N, Ishimaru F, Kondo G, et al. Syncopal-type reactions tend to be delayed and result in falls among elderly blood donors[J]. Vox Sang, 2021, 116(1): 36-41. doi: 10.1111/vox.12981

    [27]

    Masser BM, White KM, Terry DJ. Beliefs underlying the intention to donate again among first-time blood donors who experience a mild adverse event[J]. Transfus Apher Sci, 2013, 49(2): 278-284. doi: 10.1016/j.transci.2013.06.008

    [28]

    Hoogerwerf MD, Veldhuizen IJ, van den Hurk K, et al. Negative experiences and predonation blood pressure at the subsequent donation in blood donors[J]. Vox Sang, 2016, 110(2): 107-115. doi: 10.1111/vox.12319

    [29]

    Brunson DC, Belanger GA, Sussmann H, et al. Factors associated with first-time and repeat blood donation: adverse reactions and effects on donor behavior[J]. Transfusion, 2022, 62(6): 1269-1279. doi: 10.1111/trf.16893

    [30]

    de Farias CLG, Bassolli L, Mendrone-Junior A, et al. The impact of immediate adverse donation reactions on the return of volunteers undergoing platelet apheresis[J]. Transfus Apher Sci, 2022, 61(4): 103424. doi: 10.1016/j.transci.2022.103424

    [31]

    罗辰骅, 翁文浩, 孟小琴, 等. C反应蛋白/血清白蛋白对糖尿病肾病患者肾功能不全预测的研究[J]. 临床血液学杂志, 2022, 35(8): 569-573. https://lcxy.whuhzzs.com/article/doi/10.13201/j.issn.1004-2806.2022.08.008

    [32]

    肖改娥, 马莹, 李婷, 等. 血清Cys-C、β2-MG、Fetuin-A与老年糖尿病肾病的相关性研究[J]. 临床血液学杂志, 2021, 34(10): 693-696. https://lcxy.whuhzzs.com/article/doi/10.13201/j.issn.1004-2806.2021.10.003

    [33]

    Huang WX, Xu WD, Zhu P, et al. Analysis of blood glucose distribution characteristics in a health examination population in Chengdu(2007—2015)[J]. Medicine(Baltimore), 2017, 96(49): e8765.

    [34]

    Li HY, Fang KM, Peng HB, et al. The relationship between glycosylated hemoglobin level and red blood cell storage lesion in blood donors[J]. Transfusion, 2022, 62(3): 663-674. doi: 10.1111/trf.16815

    [35]

    Agarwal P, Gautam A, Pursnani N, et al. Should screening voluntary blood donors be used as strategy to diagnose diabetes and diabetic nephropathy?[J]. J Family Med Prim Care, 2020, 9(7): 3582-3585. doi: 10.4103/jfmpc.jfmpc_229_20

    [36]

    Martin S, Martin E, Klug C, et al. Diabetes studie Bayern: bekannte risikoparameter korrelieren mit erhöhten HbA1c-werten[J]. DMW Deutsche Medizinische Wochenschrift, 2007, 132(24): 1315-1320. doi: 10.1055/s-2007-982030

    [37]

    Samad NA, Yong PW, Mahendran K. Routine diabetes screening in blood donation campaigns[J]. Malays J Pathol, 2015, 37(2): 137-140.

    [38]

    Anghebem-Oliveira MI, Gobor L, Welter M, et al. Non-fasting plasma glucose concentration in blood donors[J]. Clin Chem Lab Med, 2016, 54(4): e135-e137.

    [39]

    Jońca M, Krótki F, Tomasik P. The effect of disinfecting procedure on the glucose concentration using a personal glucose meter[J]. Prim Care Diabetes, 2021, 15(5): 848-852.

    [40]

    Kubihal S, Goyal A, Gupta Y, et al. Glucose measurement in body fluids: a ready reckoner for clinicians[J]. Diabetes Metab Syndr, 2021, 15(1): 45-53.

    [41]

    Lenhard MJ, Maser RE, Kolm P, et al. Screening blood donors for diabetes: analysis of use, accuracy, and cost[J]. Transfusion, 2013, 53(11): 2776-2781.

    [42]

    Kempe-Teufel DS, Bissinger R, Qadri SM, et al. Cellular markers of eryptosis are altered in type 2 diabetes[J]. Clin Chem Lab Med, 2018, 56(7): e177-e180.

  • 加载中
计量
  • 文章访问数:  750
  • PDF下载数:  481
  • 施引文献:  0
出版历程
收稿日期:  2022-11-30
刊出日期:  2023-08-01

目录